BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16951204)

  • 41. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S-Nitrosylation of mitogen activated protein kinase phosphatase-1 suppresses radiation-induced apoptosis.
    Guan W; Sha J; Chen X; Xing Y; Yan J; Wang Z
    Cancer Lett; 2012 Jan; 314(2):137-46. PubMed ID: 22014408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
    Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
    Joo SS; Yoo YM
    J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cross-talk between the p38alpha and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation.
    Staples CJ; Owens DM; Maier JV; Cato AC; Keyse SM
    J Biol Chem; 2010 Aug; 285(34):25928-40. PubMed ID: 20547488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitogen-activated protein kinase phosphatase 1 negatively regulates MAPK signaling in mouse hypothalamus.
    Adachi K; Goto M; Onoue T; Tsunekawa T; Shibata M; Hagimoto S; Ito Y; Banno R; Suga H; Sugimura Y; Oiso Y; Arima H
    Neurosci Lett; 2014 May; 569():49-54. PubMed ID: 24686178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
    Horsch K; de Wet H; Schuurmans MM; Allie-Reid F; Cato AC; Cunningham J; Burrin JM; Hough FS; Hulley PA
    Mol Endocrinol; 2007 Dec; 21(12):2929-40. PubMed ID: 17761948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. STAMBPL1 promotes breast cancer cell resistance to cisplatin partially by stabilizing MKP-1 expression.
    Liu R; Yang G; Bao M; Zhou Z; Mao X; Liu W; Jiang X; Zhu D; Ren X; Huang J; Chen C
    Oncogene; 2022 Apr; 41(16):2265-2274. PubMed ID: 35236965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitogen-activated protein kinase phosphatase-1 prevents lipopolysaccharide-induced apoptosis in immature rat intestinal epithelial cells.
    Talavera MM; Kralik N; Jin Y; Chen B; Liu Y; Nelin LD
    Pediatr Res; 2015 Aug; 78(2):128-36. PubMed ID: 25950450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MKP-1 suppresses PARP-1 degradation to mediate cisplatin resistance.
    Wang J; Kho DH; Zhou JY; Davis RJ; Wu GS
    Oncogene; 2017 Oct; 36(43):5939-5947. PubMed ID: 28650468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interplay of MKP-1 and Nrf2 drives tumor growth and drug resistance in non-small cell lung cancer.
    Wang H; Liu K; Chi Z; Zhou X; Ren G; Zhou R; Li Y; Tang X; Wang XJ
    Aging (Albany NY); 2019 Dec; 11(23):11329-11346. PubMed ID: 31811110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
    Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
    Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MKP-1: a critical phosphatase in the biology of macrophages controlling the switch between proliferation and activation.
    Comalada M; Lloberas J; Celada A
    Eur J Immunol; 2012 Aug; 42(8):1938-48. PubMed ID: 22865045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells.
    Wang J; Zhou JY; Zhang L; Wu GS
    Cell Cycle; 2009 Oct; 8(19):3191-8. PubMed ID: 19755862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.
    Rincón R; Zazo S; Chamizo C; Manso R; González-Alonso P; Martín-Aparicio E; Cristóbal I; Cañadas C; Perona R; Lluch A; Eroles P; García-Foncillas J; Albanell J; Rovira A; Madoz-Gúrpide J; Rojo F
    Mol Cancer Ther; 2016 Nov; 15(11):2780-2790. PubMed ID: 27599524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.
    Liu R; Zheng HQ; Zhou Z; Dong JT; Chen C
    J Biol Chem; 2009 Jun; 284(25):16791-16798. PubMed ID: 19411256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance.
    Lawan A; Min K; Zhang L; Canfran-Duque A; Jurczak MJ; Camporez JPG; Nie Y; Gavin TP; Shulman GI; Fernandez-Hernando C; Bennett AM
    Diabetes; 2018 Apr; 67(4):624-635. PubMed ID: 29317435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway.
    Hocsak E; Szabo V; Kalman N; Antus C; Cseh A; Sumegi K; Eros K; Hegedus Z; Gallyas F; Sumegi B; Racz B
    Free Radic Biol Med; 2017 Jul; 108():770-784. PubMed ID: 28457938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.